Vancouver, British Columbia – TheNewswire - May 20, 2022. Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) is providing the following update regarding its common share consolidation announced on May 13, 2022.
The common shares of the Company will be consolidated on the ratio of five (5) pre-consolidated shares for one (1) post-consolidated share. Each fractional share remaining after the consolidation that is less than 1/2 of a share will be cancelled and each fractional share that is at least 1/2 of a share will be changed to one whole share.
The Company set May 27, 2022 as the record date for the consolidation of its common shares. Trading on a consolidated basis will start on May 26, 2022.
As a result, the outstanding common shares of the Company will be reduced to approximately 11,746,727 common shares.
The name and the stock symbol of the Company will not change.
The new ISIN of the Company is CA52978A2056 and the new CUSIP is 52978A205.
Letters of transmittal will be mailed to the shareholders of the Company.
On Behalf of the Board of Directors
LEXSTON LIFE SCIENCES CORP.
Jagdip Bal Chief Executive Officer
Telephone: (604) 928-8913
Copyright (c) 2022 TheNewswire - All rights reserved.